TCT for Surgeons to showcase hybrid surgical, interventional techniques during TCT 2010

'Emerging Directions for the Cardiothoracic and Vascular Surgeon' to be co-sponsored by the American Association for Thoracic Surgery

TCT for Surgeons will showcase the expansion of hybrid surgical and interventional techniques in the field that are improving outcomes for patients undergoing cardiac surgery. Now in its 4th year, the course will run during Transcatheter Cardiovascular Therapeutics (TCT) 2010 (September 21-25), the annual scientific symposium of the Cardiovascular Research Foundation.

"This meeting will drive forward the growing collaboration among interventional cardiologists and cardiac surgeons in the treatment of patients with structural and coronary artery disease," said Mathew Williams, MD, Course Director, and Surgical Director, Cardiovascular Transcatheter Therapies at NewYork-Presbyterian Hospital/Columbia University Medical Center. "The surgeon brings tremendous knowledge, a valuable skill set, and a unique perspective to the interventional environment and the cross-trained surgeon is positioned ideally to make the most informed and unbiased treatment decision for patients with coronary and endovascular disease."

One of the course highlights will be an overview of "hybrid coronary therapy," which involves a combination of traditional surgery along with the placement of coronary stents in patients with coronary artery disease. The chosen therapy, whether it is angioplasty, surgery, or a combination of the two, should be determined specifically for an individual patient, Williams said.

TCT for Surgeons will also include programs and sessions on:

  • Valvular heart disease
  • Minimally invasive surgery
  • New surgical technologies
  • Abdominal Aortic Endografting
  • Aortic Aneurysmal Disease: Overview and Imaging
  • Thoracic Aortic Endografting

The American Association for Thoracic Surgery (AATS) is cosponsoring the program.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research